Every fall, the American College of Chest Physicians (CHEST) holds its annual CHEST conference. This year, marking 90 years since CHEST was founded in 1935, CHEST 2025 will take place in Chicago, Illinois, from October 19 to October 22.
Featuring world-class educational sessions that focus on the most groundbreaking research and technologies, CHEST is a four-day event packed with networking and professional development opportunities complimented by educational, on-site simulation sessions, research presentations, and insightful lectures from some of the leading individuals advancing chest medicine worldwide.
Registration is currently open, with discounts offered for advanced purchases (through October 6) and to students, interns, retirees, and more.
As CHEST 2025 approaches, we are spotlighting some of the exciting educational sessions focused on asthma. To help you plan ahead, we’ve outlined the sessions related to asthma below. Please note that dates and times are accurate as of September 18, 2025. Consult with the event’s official website for the most up-to-date schedule.
Sunday, October 19
Selecting the Right Biologic in Asthma Management
- 11:00 AM - 12:00 PM
- Session Description: In this session attendees will explore key aspects of biologic therapy selection and discuss how to choose the right biologic for the right patient. Predictors of response to biologic therapies will be highlighted with a focus on addressing timing and approaches for biologic switching. Speakers will cover the emerging concept of clinical remission in asthma, particularly in the context of targeted therapies, and will conclude with emerging biologics in the pipeline that could address remaining unmet needs in severe asthma treatment.
In Conversation: Multidisciplinary Perspectives on Chronic Airway Diseases
- 12:00 PM – 1:15 PM
- Session Description: Recently, studies have highlighted that the prevalence of asthma in patients with chronic rhinosinusitis with nasal polyps is estimated at 60% to 70%, and severe asthma associated with nasal polyps represents more than 70% of cases.This panel discussion will focus on perspectives of the treatment paradigm and strategies for managing the intricacies of chronic inflammatory airway diseases.
- 12:00 PM – 1:15 PM
- Session Description: In this session, speakers will discuss the latest insight on severe asthma, along with strategies to address unmet patient needs. The burden of asthma on the patient and healthcare system will be examined, including racial/ethnic disparities.
Cutting-edge Asthma Updates from National Research Networks
- 1:30 PM – 2:30 PM
- Session Description: This session will delve into the latest advancements in severe asthma research, highlighting key discoveries and their translation into clinical practice.
- 2:45 PM – 3:45 PM
- Session Description: This session will feature a debate on hot topics in asthma, with the audience deciding the winner.
Asthma Comorbidities: Management Strategies
- 4:00 PM – 5:00 PM
- Session Description: Asthma control can be very challenging especially in severe and difficult to control asthma if there are co-morbidities complicating outcome. Comorbidities can influence asthma control irrespective of severity. In this session presenters will discuss how to identify and appropriately manage comorbidities.
Monday, October 20
Innovating Care for Chronic Respiratory Diseases: Targeting IL-33 and Epithelial Alarmins
- 6:00 AM – 7:30 AM
- Session Description: This session will bring together leading pulmonologists, allergists/immunologists, and critical care specialists for a moderated panel to explore multidisciplinary perspectives on IL-33 and other epithelial alarmins in respiratory disease management. The panel will discuss real-world clinical cases to deepen attendees' understanding of respiratory pathophysiology and guide the application of evidence-based strategies to personalize patient care.
Asthma: Tailoring Management for Most at Risk
- 8:00 AM – 9:00 AM
- Session Description: This session will focus on treating asthma in specific situations, including during pregnancy, with fungal sensitization, and in patients with obesity or who are uninsured.
Comparing Latest Asthma Guidelines for Mild Disease
- 9:15 AM – 10:15 AM
- Session Description: This session will provide a comprehensive review and comparison of major asthma guidelines, including the GINA document, ERS/ATS guidelines, and NAEPP guidelines.
Many Triggers, A Targeted Approach: Helping to Understand the Spectrum of Severe Asthma
- 10:15 AM – 11:00 AM
- Session Description: Amgen and AstraZeneca will share an approach that may change the way attendees view severe asthma with multiple triggers and drivers. This expert-led program will explore the clinical and safety data of a treatment option and its application to clinical practice.
Shifting the Asthma Care Paradigm: Clinical Evidence for Anti-Inflammatory Rescue
- 10:15 AM – 11:00 AM
- Session Description: AstraZeneca will cover efficacy and safety data and how this treatment option may apply to clinical practices.
- 10:20 AM – 10:50 AM
- Session Description: No description provided.
New Innovations in Asthma and COPD
- 10:20 AM – 10:50 AM
- Session Description: No description provided.
- 11:00 AM – 12:00 PM
- Session Description: No description provided.
Severe Asthma Across the Lifespan: Shared Challenges and Innovative Solutions
- 11:00 AM – 12:00 PM
- Session Description: Attendees will explore the shared challenges of managing severe asthma across pediatric and adult populations while highlighting innovative solutions in outpatient care, biologic therapies, and acute management, fostering a unified approach to improving patient outcomes across the lifespan.
Mastering Biologics in Asthma: Problem-based Learning 2025
- 1:30 PM – 2:30 PM
- Session Description: No description provided. This session requires an additional fee.
Beyond the Inhaler: Systems-based Innovations in Asthma Care
- 1:30 PM – 2:30 PM
- Session Description: No description provided.
Advances in Non-Type 2 Severe Asthma: Mechanisms and Therapeutics
- 3:15 PM – 4:15 PM
- Session Description: This session will provide an update on non-T2 asthma, focusing on its pathophysiology, diagnosis, and management strategies. Experts will discuss the mechanisms that drive non-T2 asthma, highlighting differences with T2 asthma in terms of inflammatory pathways and clinical presentation. The session will discuss current definitions that are used to diagnose these patients and new biomarkers that are being developed. Management approaches, including pharmacologic treatments including inhalers, oral medications, and injectable biologics will be reviewed. Attendees will explore what's upcoming in the management and understanding of non-T2 asthma.
Tuesday, October 21
Biologics in Severe Asthma Advances: The Latest Innovations
- 8:00 AM – 9:00 AM
- Session Description: This session delves into the latest advances in biologics for severe asthma. Attendees will explore how to move beyond phenotypes and incorporate factors like small airway disease, mucus score, hyperinflation, and lung function when deciding on biologic therapy. Attendees will hear from an allergist on the role of immunotherapy, dual biologics, and important considerations when treating immunosuppressed patients. The session will wrap up with an overview of the newest innovations in biologic therapies for 2025 and what's on the horizon.
Asthma Diagnosis and Evaluation: The New Tools
- 9:15 AM – 10:15 AM
- Session Description: Variable expiratory airflow limitation, often assessed by bronchodilator challenge, is a defining feature of asthma, but is not reliably demonstrated on spirometry. Moreover, the routine use of bronchodilator responsiveness testing has recently been called into question. Additionally, FENO measurement and Oscillometry are now considered important tools in the diagnostic toolbox. This session will include 20 minute presentations by experts in the field on bronchodilator responsiveness, FENO, and oscillometry.
Many Paths, One Goal: How Can We Strive for More in Severe Asthma Management
- 10:30 AM – 11:15 AM
- Session Description: This session will be an engaging and educational discussion on the chronic inflammatory nature of asthma, driven by type 2 inflammation, and the role of IL-5 in its pathophysiology.
Taking Control: The Urgent Need to Identify and Address Uncontrolled Asthma
- 12:30 PM – 1:15 PM
- Session Description: This session will explore how patients and clinicians often overestimate asthma control and to evaluate the clinical merits of the Asthma Impairment and Risk Questionnaire (AIRQ) over other asthma control tools.
Asthma: Biologics and Comorbid Conditions
- 1:45 PM – 2:30 Pm
- Session Description: No description provided.
- 1:45 PM – 2:30 PM
- Session Description: No description provided.
90 Years of Progress: Asthma – Past, Present, and Future
- 2:45 AM – 3:45 AM
- Session Description: In celebration of 90 years of CHEST, take a guided look at the past, present, and future of research in asthma, exploring the evolution of patient care and clinical practice.
Wednesday, October 22
- 8:00 AM – 9:00 AM
- Session Description: In this session, experts will provide attendees with updates on recent pivotal trials in asthma conducted over the past 1-2 years. This session aims to enhance the medical knowledge of both adult and pediatric pulmonary practitioners.
At a Crossroads: Recognizing and Addressing Barriers to Asthma Control
- 12:30 PM – 1:15 PM
- Session Description: Join a leading asthma expert, Dr. Farooqui, as they rethink solutions to critical unmet needs in uncontrolled asthma. This event will examine how disease and treatment burden can hinder asthma management, highlight the benefit of shared decision-making, and uncover opportunities along the patient journey to drive lasting asthma control.
Sign up for alerts and stay informed on more upcoming conference previews and conference recaps.
Copyright © 2025 Guideline Central, all rights reserved.